Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Down 74.9% in September

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSCGet Free Report) saw a large decline in short interest in September. As of September 30th, there was short interest totaling 9,900 shares, a decline of 74.9% from the September 15th total of 39,500 shares. Based on an average trading volume of 30,900 shares, the days-to-cover ratio is presently 0.3 days. Based on an average trading volume of 30,900 shares, the days-to-cover ratio is presently 0.3 days.

Cardiac Biotech Solutions Stock Performance

OTCMKTS:CBSC opened at $0.05 on Friday. The company has a fifty day moving average of $0.04 and a 200-day moving average of $0.04. Cardiac Biotech Solutions has a twelve month low of $0.02 and a twelve month high of $0.15.

Cardiac Biotech Solutions Company Profile

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Further Reading

Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.